Transaction DateRecipientSharesTypePriceValue
25th January 2021Jeffrey E. Eberwein938Open or private purchase$13.01$12,203.38
22nd January 2021Jeffrey E. Eberwein371Open or private purchase$13.38$4,963.98
21st January 2021Jeffrey E. Eberwein1,000Open or private purchase$13.65$13,650.00
15th January 2021Jeffrey E. Eberwein1,330Open or private purchase$11.36$15,108.80
31st December 2020Jeffrey E. Eberwein3,498Grant/award etc.$0.00
30th November 2020David J. Noble3,000Open or private sale$2.97$8,910.00
19th November 2020Jeffrey E. Eberwein7,866Open or private purchase$2.46$19,350.36
18th November 2020Jeffrey E. Eberwein12,134Open or private purchase$2.52$30,577.68
9th November 2020David J. Noble1,916Exercise of derivative$0.00
27th October 2020Dimitrios Angelis12,387Grant/award etc.$2.22$27,499.14
Digirad Corporation
Digirad Corporation logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.


Digirad Corp. engages in the provision of mobile healthcare solutions. It operates through the following segments: Diagnostic Services, Mobile Healthcare, and Diagnostic Imaging. The Mobile Healthcare segment provides contract diagnostic imaging, including computerized tomography, magnetic resonance imaging, positron emission tomography and healthcare expertise to hospitals. The Diagnostic imaging segment develops solid-state gamma cameras, imaging systems and camera maintenance contracts.


Ticker: DRAD
Sector: Healthcare
Industry: Medical Devices
SEC Central Index Key (CIK): 707388
Employees: 452
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals
Cash at Carrying Value: $9 M (400%)
Inventory, Net: $8 M (0%)
Other Assets, Current: $1 M (-20%)
Assets, Current: $33 M (11%)
Property, Plant and Equipment, Net: $19 M (0%)
Other Assets, Noncurrent: $997 Th (-14%)
Assets: $89 M (-1%)
Long-term Debt, Current Maturities: $4 M (0%)
Accounts Payable, Current: $6 M (-34%)
Liabilities, Current: $24 M (-13%)
Long-term Debt, Excluding Current Maturities: $19 M (12%)
Other Liabilities, Noncurrent: $1 M (-28%)
Liabilities: $48 M (-4%)
Common Stock, Shares, Issued: $5 M (128%)
Retained Earnings (Accumulated Deficit): $123 M (0%)
Treasury Stock, Value: $57 Th (0%)
Treasury Stock, Shares: $3 M (0%)
Stockholders' Equity (Parent): $21 M (0%)
Liabilities and Equity: $89 M (-1%)
Cost of Revenue: $18 M (-57%)
Gross Margin: $4 M (0%)
Sales and Marketing: $5 M (-56%)
Operating Income/Loss: $2 M (1%)
Other Income, net: $289 Th (1011%)
Provision for income taxes: $50 Th (-40%)